In News Centre

Enter a keyword or phrase to search all pages in this section:


Advanced search

Archive:

Looking for a previously published document in this section?

Earlier access to medicines: Report from the Ministerial Industry Strategy Group (MISG) Forum

The second Forum set up under the Ministerial Industry Strategy Group (MISG) met in September 2007 to debate whether making medicines available to patients at an earlier stage of their development was feasible and desirable. The topic of earlier access to medicines was chosen by the Panel to provide a preliminary consideration of a recommendation made by Sir David Cooksey in his Review of UK Health Research Funding  (external link). This report recommends conditional licensing of new drugs at an earlier stage in the development process (for example, at the end of Phase II of the clinical trial). It also recommends allowing clinical use under strict controls, plus a systematic programme of pilot studies of conditional licensing for new drugs at an earlier stage, allowing initial use by specialists - but not General Practitioners (GPs) - in the context of a randomised control trial.

Page last modified: 25 January 2008